Final results from the phase 3 CASSANDRA trial presented at the 2025 ASCO Meeting show that the neoadjuvant chemotherapy ...

Please provide your email address to receive an email when new articles are posted on . In 2020, the global lifetime risk for developing and dying from gastrointestinal cancers was 8.2% and 6.17%.

A study at two US medical centers found that patients with brain metastases from gastrointestinal (GI) cancers had significantly worse overall survival and intracranial progression-free survival (PFS) ...

Dr. John Gaetano performs a colonoscopy on Mike Lowe, 45, at Northwestern Lake Forest Hospital on April 18. (Stacey Wescott / Chicago Tribune via Getty Images file) Gastrointestinal cancers, which ...

Gastrointestinal cancers that once resisted checkpoint inhibitors are finally responding to novel combination strategies([1]) , with the FDA fast-tracking multiple targeted therapies designed to ...

Tiago Biachi, MD, PhD, highlighted the transformative role of personalized medicine in gastrointestinal (GI) cancer treatment through advances in next-generation sequencing and circulating tumor DNA, ...

Gastrointestinal cancers can seriously affect the digestive tract. While experts have not identified exact causes, these ...

A recent study has identified a potential new tool to help detect gastrointestinal cancers — the platelet-to-high-density lipoprotein ratio, or PHR. Researchers analyzed data from more than 19,000 ...

In recent years, there has been a concerning trend of increasing cases of colorectal and other gastrointestinal (GI) cancers in younger people. Despite being more common in older adults, early-onset ...

The liver is an extremely sensitive organ. It filters blood, eliminates toxins and creates bile to digest food; without a functioning liver, a person will die. Its sensitive nature, however, makes it ...